SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-20-216509
Filing Date
2020-08-11
Accepted
2020-08-11 17:30:25
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d941995d424b5.htm 424B5 362190
2 GRAPHIC g941995g55d35.jpg GRAPHIC 65398
3 GRAPHIC g941995g79j32.jpg GRAPHIC 42714
  Complete submission text file 0001193125-20-216509.txt   500864
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-244401 | Film No.: 201093516
SIC: 2834 Pharmaceutical Preparations